| Identification | Back Directory | [Name]
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-(pyridin-4-yl)butanoic acid | [CAS]
273222-04-1 | [Synonyms]
Fmoc-Abu(4-pyridyl)-OH
Fmoc-(S)-2-amino-4-(4-pyridyl)butyric acid
4-Pyridinebutanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (αS)-
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-(pyridin-4-yl)butanoic acid | [Molecular Formula]
C24H22N2O4 | [MOL File]
273222-04-1.mol | [Molecular Weight]
402.45 |
| Hazard Information | Back Directory | [Uses]
(S)-N-Fmoc-[2-(4-pyridyl)ethyl]glycine is a protected pyridylethylglycine that was used in the design and synthesis of peptide-doxorubicin prodrugs as anti-tumor agents. |
|
| Company Name: |
Shanghai GL Peptide Ltd.
|
| Tel: |
+86-21-61263340; 17609490614 13764994101 |
| Website: |
https://www.chemicalbook.com/supplier/10480342/ |
|